Skip to main content
OpenTrials

Clinical trial condition

Allogeneic Hematopoietic Cell Transplantation (HCT)

Explore clinical trials studying Allogeneic Hematopoietic Cell Transplantation (HCT). Study availability and eligibility vary by location and protocol.

3 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Allogeneic Hematopoietic Cell Transplantation (HCT) trial results

Recruiting

MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib

NCT07463651

Conditions
Acute Myeloid Leukemia (AML), Allogeneic Hematopoietic Cell Transplantation (HCT), FLT3-ITD Mutation, +10 more
Locations
  • the First Affiliated Hosptital of Soochow University Suzhou, Jiangsu, China
  • Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China
View Trial Details
Recruiting

Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML

NCT07304232

Conditions
AML (Acute Myeloid Leukemia), Allogeneic Hematopoietic Cell Transplantation (HCT), Hematologic Diseases, +6 more
Locations
  • The Second Hospital of Hebei Medical University Shijiazhuang, Hebei, China
  • The First Affiliated Hospital of Harbin Medical University Harbin, Heilongjiang, China
  • Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
  • Tianjin Medical University General Hospital Tianjin, Tianjin Municipality, China
View Trial Details

Related conditions